Rpg Investment Advisory, LLC Amgen Inc Transaction History

Rpg Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $7,955 - $9,104	-40 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $4,216 - $4,913	-19 Reduced 32.2%	40 $10,000
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $11,670 - $14,321	59 New	59 $14,000
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $3,705 - $4,177	-20 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1,863 - $2,178	-11 Reduced 35.48%	20 $3,000
Q3 2017 Feb 05, 2019	BUY	$167.29 - $191.0 $5,185 - $5,921	31	31 $6,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rpg Investment Advisory, LLC with notifications on news.